1. Introduction {#sec0005}
===============

Lamoids, or llamas, belong to a family of camelids which are economically important livestock and have developed complex features and immunological traits related to their habitat ([@bib1190]; [@bib0925]). The llama (*Lama glama*), Bactrian camel (*Camelus bactrianus*), dromedary (*Camelus dromedarius*) and alpaca (*Vicugna pacos*) differ in their habitat. The Bactrian camel and dromedary are adapted to arid-desert-adapted environments, alpacas to plateaus, and the llama to higher altitudes. Llamas are historically found in the Andean highlands, specifically the Altiplano of southeast Perú and western Bolivia, as well as in Chile and Argentina, which has the third highest population of llamas ([@bib1190]). The domesticated llama is closely related to two extant wild South American camelids, the vicuña (*Vicugna vicugna*) and guanaco (*Lama guanicoe*). Previous genomic studies have revealed a range of specific adaptions in camelids relating to fat and water metabolism, osmoregulation, blood glucose level regulation, stress responses to heat, aridity, as well as to intense ultraviolet radiation and dust ([@bib1190]). Furthermore, a particularly important feature in camelid immunity is the production of small, homodimeric heavy chain-only, antibodies (HCAbs) which are of great value for the biomedical industry ([@bib0460]).

Peptidylarginine deiminases (PADs) are phylogenetically conserved calcium-dependent enzymes which post-translationally convert arginine into citrulline in target proteins in an irreversible manner. This can cause functional and structural changes in target proteins (Vossenaar, 2003; [@bib0420]; [@bib1140]; [@bib0115]). Structures most prone to deimination are beta-sheets and intrinsically disordered proteins, while the position of the arginine is also important; arginines sitting next to aspartic acid residues are most prone to citrullination, arginines next to glutamic acid residues are rarely citrullinated and those flanked by proline are poorly citrullinated ([@bib0790]; [@bib1050]; [@bib0420]). Protein deimination can affect gene regulation, cause generation of neoepitopes ([@bib1185]; [@bib0620]) and may also allow for protein moonlighting, an evolutionary acquired phenomenon facilitating proteins to exhibit several physiologically relevant functions within one polypeptide chain ([@bib0455]; [@bib0520]; [@bib0685]). PADs have been identified throughout phylogeny from bacteria to mammals, with 5 tissue specific PAD isozymes in mammals, 3 in chicken, 1 in bony fish and arginine deiminase homologues in bacteria ([@bib1125]; [@bib0880]; [@bib0685], [@bib0695]; [@bib0580]). While studies on PADs in relation to human pathophysiology, including cancer, autoimmune and neurodegenerative diseases ([@bib1140]; [@bib1185]; [@bib0620]; [@bib0570] & [@bib0575]) and CNS regeneration ([@bib0610] and [@bib0615]) exist, relatively little phylogenetic research has been carried out on PADs in relation to normal physiology and evolutionary acquired adaptions of the immune system. Recent comparative studies focussing on roles for PADs in teleost fish have identified post-translational deimination in key proteins of innate, adaptive and mucosal immunity ([@bib0685], [@bib0690]; Magnadottir et al., 2019a; [@bib0700]). A recent study in shark also revealed novel insights into this post-translational modification in relation to key immune factors, including shark immunoglobulins ([@bib0200]). As the camelid family has developed unusual small immunoglobulins similar as to shark through convergent evolution, indicating common factors between shark and camelid immunity, we felt that an investigation of post-translationally deiminated proteins in camelids was warranted.

As PADs have been identified to be a key regulator of extracellular (EV)-release, a mechanism that has been found to be phylogenetically conserved from bacteria to mammals ([@bib0535]; [@bib0570], [@bib0575]; [@bib0365]; [@bib0580]), the characterisation of EVs in camelids is of further interest. Extracellular vesicles (EVs) are found in most body fluids and participate in cellular communication via transfer of cargo proteins and genetic material ([@bib0510]; [@bib0190]; [@bib0620]; [@bib1080]; [@bib1090]). EVs in body fluids, including serum, can also be useful biomarkers to reflect health status ([@bib0465]; [@bib0870]). Previous work on EVs has hitherto mainly been in the context of human pathologies, while recently comparative studies are growing ([@bib0495]; [@bib1215]; [@bib0700]; [@bib0200]; [@bib0365]; [@bib0580]). Few studies have been performed on EVs in camelids but therapeutic effects of EVs isolated from camel milk have been identified in halting cancer progression ([@bib0045]). A recent study in shark identified for the first time deiminated small immunoglobulin proteins as part of EV cargo ([@bib0200]). Due to the link between camelid and shark immunity through convergent evolution including the unusual immunoglobulin structure of small heavy chain-only Ig's, a comparative study on EVs and deiminated EV cargo in a camelid species may provide further insights into shared immunological traits. Camelids have an unusual Ig repertoire and a large diversity of functional nanobodies has been identified in the llama ([@bib0440]; [@bib0240]). This has made camelids an important source for small immunoglobulins that can be used for immunotherapy purposes, including for tumour targeting ([@bib1100]), as well as for assessing cancer metastasis ([@bib0875]). As these nanobodies can also penetrate the blood-brain barrier ([@bib0990]) they are of great value for a range of therapeutic treatment applications, including for brain cancers ([@bib0515]). Furthermore, as the camelid family has acquired unique metabolic features, they are also of interest as a model species for informing metabolic diseases.

In the current study we assessed post-translationally deiminated proteins in llama serum and serum-derived EVs, and report for the first time EV-mediated export of deiminated key immune, metabolic and nuclear proteins in serum of a camelid species.

2. Materials and methods {#sec0010}
========================

2.1. Animals and sampling {#sec0015}
-------------------------

Llama (*Lama glama* L. 1758) serum was shared from excess blood collected in routine health checks of a resident male llama at the Texas A&M Winnie Carter Wildlife Center. Blood collected from the jugular vein of this 21 year old llama was allowed to clot at room temperature for 2 h before serum was collected by centrifuging at 300 *g* for 10 min. Serum was aliquoted and immediately frozen at −80 °C until further use.

2.2. Extracellular vesicle (EV) isolation and nanoparticle tracking analysis (NTA) {#sec0020}
----------------------------------------------------------------------------------

EVs were isolated by step-wise centrifugation according to established protocols using ultracentrifugation and the recommendations of MISEV2018 (the minimal information for studies of extracellular vesicles 2018; [@bib1060]). Llama serum was diluted 1:5 in ultrafiltered (using a 0.22 μm filter) Dulbecco's PBS (DPBS, 100 μl serum added to 400 μl DPBS) and then centrifuged at 4000 *g* for 30 min at 4 °C for removal of cells and cell debris. The supernatant was collected and centrifuged at 100,000 *g* for 1 h at 4 °C. The pellet was then resuspended in DPBS and washed again at 100,000 *g* for 1 h at 4 °C. The resulting EV-enriched pellet was resuspended in 100 μl DPBS, diluted 1/100 in DPBS and analysed by NTA, based on Brownian motion of particles in suspension, using the NanoSight NS300 system (Malvern, UK). The NanoSight was used in conjunction with a syringe pump to ensure continuous flow of the sample, with approximately 40--60 particles per frame and videos were recorded for 5 x 90 s. The replicate histograms generated from the recordings were averaged.

2.3. Transmission electron microscopy (TEM) {#sec0025}
-------------------------------------------

EVs were isolated from serum as described above, the EV pellets were fixed with 2.5 % glutaraldehyde in 100 mM sodium cacodylate buffer (pH 7.0) for 1 h at 4 °C, resuspended in 100 mM sodium cacodylate buffer (pH 7.0), placed on to a grid with a glow discharged carbon support film, stained with 2 % aqueous uranyl acetate (Sigma-Aldrich) and thereafter viewed in TEM. Imaging was performed using a JEOL JEM 1400 transmission electron microscope (JEOL, Japan) operated at 80 kV at a magnification of 80,000--100,000. Digital images were recorded using an AMT XR60 CCD camera (Deben, UK).

2.4. Western blotting {#sec0030}
---------------------

Llama serum and EV isolates (an EV pellet derived from 100 μl serum, reconstituted in 100 μl DPBS after isolation and purification) were diluted 1:1 in 2x Laemmli sample buffer, boiled for 5 min at 100 °C and separated by SDS-PAGE on 4--20 % gradient TGX gels (BioRad UK). Approximately 5 μg protein was loaded per lane and transferred to nitrocellulose membranes using semi-dry Western blotting. Blocking of membranes was performed in 5 % BSA in TBS-T for 1 h at room temperature (RT) and incubation with primary antibodies, diluted in TBS-T, was carried out at 4 °C overnight (F95 MABN328, Merck, 1/1000; PAD2 ab50257, Abcam, 1/1000; PAD3 ab50246, 1/1000; PAD4 ab50247, 1/1000; citH3 ab5103, 1/1000; CD63 ab216130, 1/1000; Flot-1 ab41927, 1/2000). The membranes were washed in TBS-T for 3 × 10 min at RT and thereafter incubated in the corresponding secondary antibody (anti-rabbit IgG BioRad or anti-mouse IgM BioRad, diluted 1/4000 in TBS-T) for 1 h at RT. Membranes were washed for 6 × 10 min in TBS-T and visualisation performed using electrochemiluminescence (ECL) and the UVP BioDoc-ITTM System (Thermo Fisher Scientific, UK).

2.5. Immunoprecipitation and identification of deiminated proteins in llama serum and EVs {#sec0035}
-----------------------------------------------------------------------------------------

For isolation of total deiminated proteins from llama serum and serum derived EVs, the Catch and Release immunoprecipitation kit (Merck, UK) was used together with the F95 pan-deimination antibody (MABN328, Merck), which has been developed against a deca-citrullinated peptide and specifically detects proteins modified by citrullination ([@bib0775]). For F95 enrichment, 50 μl serum was used according to the manufacturer's instructions (Merck). For EVs, total protein was first extracted from EV-enriched pellets derived from 100 μl serum, using 100 μl radioimmunoprecipitation assay (RIPA) buffer, containing protease inhibitor cocktail (P8340, Sigma, UK), and shaken gently on ice for 2 h. Thereafter proteins were isolated from the EVs by centrifugation at 16,000 *g* for 30 min, collecting the supernatant containing the proteins. Immunoprecipitation was carried out according to the manufacturer's instructions (Merck), using a rotating platform overnight at 4 °C. The F95 bound proteins were eluted using denaturing elution buffer, according to the manufacturer's instructions (Merck). The F95 enriched eluates were then either analysed by Western blotting or by LC---MS/MS (Cambridge Proteomics, Cambridge, UK). For LC---MS/MS, the F95-enriched eluates were run 1 cm into a SDS-PAGE gel and the whole F95-enriched eluate was cut out as one band, whereafter it was processed for proteomic analysis (carried out by Cambridge Proteomics). Peak files were submitted to in-house Mascot (Matrix Science; Cambridge Proteomics). Databases used for protein identification (in house, Cambridge Proteomics) were as follows: Camelidae_family_20190613 (21429 sequences; 9086806 residues) and also specifically for llama: *Lama_glama*\_20190613 (234 sequences; 52757 residues).

3. Results {#sec0040}
==========

3.1. EV analysis in llama serum {#sec0045}
-------------------------------

EVs from llama serum were characterised, following step-wise ultracentrifugation, by size exclusion using NTA, by morphological analysis using TEM and by Western blotting using EV-specific markers ([Fig. 1](#fig0005){ref-type="fig"} ). A poly-dispersed population of EVs in the size range of 30--576 nm, with main peaks at 38, 119, 167, 237, 323 and 403 nm was identified by NTA analysis ([Fig. 1](#fig0005){ref-type="fig"}A). Western blotting confirmed that the llama serum EVs were positive for the EV-specific markers CD63 and Flotillin-1 ([Fig. 1](#fig0005){ref-type="fig"}B). TEM analysis confirmed a poly-dispersed EVs population ([Fig. 1](#fig0005){ref-type="fig"}C).Fig. 1Extracellular vesicles (EVs) isolated from llama serum. **A.** Nanoparticle tracking analysis shows a poly-dispersed population of EVs in the size range of 30--576 nm, with main peaks at 38, 119, 167, 237, 323 and 403 nm. **B.** Llama serum EVs are positive for the EV-specific markers CD63 and Flotillin-1 (Flot-1). **C.** Transmission electron microscopy (TEM) imaging of EVs isolated from llama serum shows a polydispersed population; scale bar represents 100 nm.Fig. 1

3.2. PAD and deiminated proteins in llama serum {#sec0050}
-----------------------------------------------

A cross-reaction with human PAD2, 3 and 4 isozyme-specific antibodies was observed in llama serum by Western blotting, at an approximate 70--75 kDa size range as expected for mammalian PADs ([Fig. 2](#fig0010){ref-type="fig"} A). Deiminated histone H3 was also detected in llama serum by Western blotting at the expected approximate 20 kDa size ([Fig. 2](#fig0010){ref-type="fig"}A). Total deiminated proteins in llama serum-EVs were detected by Western blotting using the F95 pan-deimination antibody, revealing a range of proteins between 25--100 kDa in size ([Fig. 2](#fig0010){ref-type="fig"}B). Deiminated proteins were also assessed by Western blotting after F95 enrichment, using immunoprecipitation (IP) from llama serum and serum-derived EVs ([Fig. 2](#fig0010){ref-type="fig"}C). Deiminated proteins from the F95 enriched eluates were further identified by LC--MS/MS analysis. In llama serum, 103 hits for camelid proteins were identified, as listed in [Table 1](#tbl0005){ref-type="table"} and Supplementary Table 1. Overall, 43 of these deiminated protein hits were common to whole serum and serum-derived EVs, while 60 hits were specific for whole serum ([Fig. 2](#fig0010){ref-type="fig"}D).Fig. 2Western blotting of deiminated proteins and PAD in llama serum. **A.** Llama PAD homologues were identified at the expected size of approximately 70--75 kDa using the anti-human PAD2, PAD3 and PAD4 isozyme specific antibodies respectively. Deiminated histone H3 (citH3), representative of neutrophil extracellular traps (NETs), was verified in llama serum. **B.** Total deiminated proteins were assessed by Western blotting in llama serum EVs, using the F95 pan-deimination specific antibody. **C.** Immunoprecipitated (IP) deiminated proteins after F95-enrichment were assessed both in serum-EVs and whole serum of llama by Western blotting. **D.** The Venn diagram represents deiminated proteins identified in total serum and serum-derived EVs by F95 enrichment and LC--MS/MS analysis. Overall, 43 proteins were identified in common with both samples, while 60 proteins were found deiminated in serum only and 25 proteins were identified as deiminated in EVs only.Fig. 2Table 1Deiminated proteins identified by F95 enrichment and LC--MS/MS in total serum of llama (*Lama glama*). Deiminated proteins were isolated by immunoprecipitation using the pan-deimination F95 antibody. The F95 enriched eluate was analysed by LC--MS/MS and peak list files were submitted to in-house Mascot (Cambridge Proteomics). Peptide sequence hits scoring with *Lama glama* (LAMGL) are included as well as hits with other camelids (CAMFR=*Camelus ferus*; CAMDR=*Camelus dromedaries*; LAMGU=*Lama guanicoe;* VICPA=*Vicugna pacos* (Alpaca)). Hits with uncharacterized proteins are omitted in the list. For a full list of peptide sequences and *m/z* values see Supplementary Table 1. An asterix (\*) indicates that the protein hit is specific to whole serum only.Table 1Protein name (\*unique for serum)Number of peptide sequences identifiedTotal score (*p*\<0.05)[ⱡ](#tblfn0005){ref-type="table-fn"}\*O97643_LAMGL*6*282Fibrinogen A-alpha chain\*P01973\|HBA_LAMGL*5*189Hemoglobin subunit alphaP68226\|HBB_LAMGL*4*166Hemoglobin subunit betaQ865W8_LAMGL*4*109Beta actinA0A1W5VKM5_LAMGL*2*117Anti-RON nanobody\*A0A1W5VKM7_LAMGL*2*111Anti-RON nanobody\*A0A1W5VKR8_LAMGL*2*96Anti-RON nanobody\*A0A1W5VKQ9_LAMGL*1*66Anti-RON nanobodyS9XDK9_CAMFR*34*1575Complement C3-like proteinS9WI87_CAMFR*20*972Serum albuminS9XAP9_CAMFR*9*522Keratin, type I cytoskeletal 14-like proteinS9Y6J1_CAMFR*11*502Keratin, type II cytoskeletal 5 isoform 13-like protein\*S9 × 688_CAMFR*10*462Keratin 6A-like protein\*S9YD43_CAMFR*9*443Complement component 4A-like protein\*S9Y253_CAMFR*8*380Kininogen-2 isoform I\*T0MII3_CAMFR*7*371Alpha-2-macroglobulin-like proteinS9XI90_CAMFR*8*357Keratin, type II cytoskeletal 75-like isoformS9 × 494_CAMFR*6*285Keratin, type I cytoskeletal 42S9XBS9_CAMFR*6*263Ig gamma-3 chain C region\*S9XYY2_CAMFR*5*246HemopexinA0A075T9L1_CAMDR*4*174Dipeptidylpeptidase 4S9XXW2_CAMFR*3*172Fibrinogen beta chain\*S9WDV3_CAMFR*3*169Fibrinogen gamma chain isoform gamma-B\*A0A1K0GY87_VICPA*4*166Globin A1S9WB99_CAMFR*3*146Histone H2BS9XNF8_CAMFR*3*142Xaa-Pro dipeptidase\*S9YS49_CAMFR*3*132Putative E3 ubiquitin-protein ligase Roquin\*S9YGW7_CAMFR*3*123Heparin cofactor 2S9WPM4_CAMFR*3*115AdiponectinA2V743_CAMDR*4*109Beta actin\*S9XP08_CAMFR*1*109Inter-alpha-trypsin inhibitor heavy chain H1*2*S9XM15_CAMFR*2*FerritinT0NNK2_CAMFR*1*93L-lactate dehydrogenaseS9 × 3E8_CAMFR*1*90Ig kappa chain V-II region RPMI 6410-like proteinA0A0A0PAR2_CAMDR*2*88Heat shock protein 90\*S9XYF2_CAMFR*2*87Heat shock cognate protein HSP 90-beta-like isoform 3S9XHZ4_CAMFR*1*83Phosphotriesterase-related proteinS9XM68_CAMFR*2*73Xaa-Pro dipeptidase isoform 3S9WT57_CAMFR*2*73Tubulin beta chain\*S9YV02_CAMFR*1*69Non-specific protein-tyrosine kinase\*S9XC57_CAMFR*1*63Plasminogen\*S9YL21_CAMFR*2*62Apolipoprotein A-I\*S9WKZ8_CAMFR*1*62Inter-alpha-trypsin inhibitor heavy chain H4S9WIA5_CAMFR*1*61Glutathione synthetaseT0MHN9_CAMFR*1*60Pyruvate kinase\*S9Y4U4_CAMFR*1*58Complement C1q subcomponent subunit C isoform 2S9WAX5_CAMFR*2*57Unconventional myosin-Va isoform 2S9WVY1_CAMFR*1*56Actinin, alpha 1 isoform 6-like proteinS9XA40_CAMFR*1*55Heat shock cognate protein\*S9YFM0_CAMFR*1*52Keratin, type II cytoskeletal 71A0A0U2KTX5_CAMDR*1*52VHH5 (Fragment)S9XR87_CAMFR*1*50Ig lambda chain C regions isoform 19-like proteinS9WGH8_CAMFR*1*49LysozymeS9WMX2_CAMFR*2*49Dystonin\*S9 × 8K9_CAMFR*1*46Transaldolase\*T0NM23_CAMFR*2*45RootletinS9W6I0_CAMFR*1*45FerritinS9WF34_CAMFR*1*43Tubulin alpha chain\*S9YSI7_CAMFR*1*43Triosephosphate isomerase\*S9XSQ6_CAMFR*1*40Vitamin [d]{.smallcaps}-binding protein-like protein\*S9YMC0_CAMFR*2*40Transcription factor 20 isoform 1\*S9Y636_CAMFR*1*39Receptor-type tyrosine-protein phosphatase-like N\*S9 × 6M4_CAMFR*1*37Dyslexia-associated proteinT0MH94_CAMFR*1*36Rabenosyn-5-like proteinS9WJW3_CAMFR*1*35N6-adenosine-methyltransferase subunit\*A8IY99_LAMGU*1*35Gamma-fibrinogenS9WRI7_CAMFR*1*35Nuclear receptor coactivator 5 isoform 3-like proteinS9W421_CAMFR*1*35Hemoglobin, epsilon 1\*S9W711_CAMFR*1*34Charged multivesicular body protein 4c\*S9 × 089_CAMFR*1*34Ig lambda chain V-III region LOI-like proteinS9WUC8_CAMFR*1*32Ig kappa chain V-II region RPMI 6410-like protein\*S9WVI6_CAMFR*1*32Complement C1q subcomponent subunit A\*S9Y5S1_CAMFR*1*32Transcriptional repressor NF-X1\*S9YC53_CAMFR*1*32Alpha-1-antitrypsin-like protein\*S9Y3F6_CAMFR*1*31Dual specificity testis-specific protein kinase 1S9WKI8_CAMFR*1*31HEAT repeat-containing protein 7B1\*S9WVS9_CAMFR*1*29Peroxisome proliferator-activated receptor gamma coactivator-related protein 1\*S9XVK5_CAMFR*1*29Transthyretin\*S9Y967_CAMFR*1*28General transcription factor II, i isoform 4 isoform 1-like protein\*T0MC04_CAMFR*1*28Spermatogenesis-associated protein 2-like protein\*S9YSZ6_CAMFR*1*28Centromere protein J[^1]

3.3. Identification of deiminated proteins in EVs from llama serum {#sec0055}
------------------------------------------------------------------

Llama serum-derived EVs showed positive for deiminated proteins by Western blotting, using the pan-deimination F95 antibody ([Fig. 2](#fig0010){ref-type="fig"}B). Deiminated proteins were further identified by F95 enrichment and LC--MS/MS analysis, revealing 68 deiminated protein hits in total for EVs, with 25 hits unique to EVs (not identified from serum). Peptide sequences of hits with camelid proteins and *m/z* values are listed in [Table 2](#tbl0010){ref-type="table"} and Supplementary Table 2. Overlap with deiminated proteins identified in whole llama serum and EVs is represented in the Venn diagram in [Fig. 2](#fig0010){ref-type="fig"}D.Table 2Deiminated proteins identified by F95 enrichment and LC--MS/MS in EVs isolated from serum of llama (*Lama glama*). Deiminated proteins were isolated by immunoprecipitation using the pan-deimination F95 antibody, the F95 enriched eluate was analysed by LC--MS/MS and peak list files were submitted to Mascot. Peptide sequence hits scoring with L. *Lama glama* (LAMGL) are presented as well as hits with other camelids (CAMFR=*Camelus ferus*; CAMDR=*Camelus dromedaries*; LAMGU=*Lama guanicoe*). Hits with uncharacterised proteins are not listed. For a full list of peptide sequences and *m/z* values see Supplementary Table 2. An asterix (\*) indicates that the protein hit is unique for EVs only.Table 2Protein name (\*unique for EVs)Number of peptide sequences identifiedTotal score (*p*\<0.05)[ⱡ](#tblfn0010){ref-type="table-fn"}A0A1W5VKM5_LAMGL*2*164Anti-RON nanobodyQ865W8_LAMGL*2*85Beta actin\*S9XAP9_CAMFR*9*554Keratin, type I cytoskeletal 14-like protein\*S9 × 688_CAMFR*10*496Keratin 6A-like proteinS9Y6J1_CAMFR*10*438Keratin, type II cytoskeletal 5 isoform 13-like proteinS9WI87_CAMFR*9*430Serum albumin\*S9YN99_CAMFR*6*417Keratin, type I cytoskeletal 17-like isoform\*S9XI90_CAMFR*6*318Keratin, type II cytoskeletal 75-like isoformS9 × 494_CAMFR*5*269Keratin, type I cytoskeletal 42S9XBS9_CAMFR*4*162Ig gamma-3 chain C regionA0A075T9L1_CAMDR*3*153Dipeptidylpeptidase 4S9 × 684_CAMFR*2*136Keratin, type II cytoskeletal 8S9WB99_CAMFR*3*133Histone H2BS9YQ51_CAMFR*3*114Tubulin beta chain\*S9WX81_CAMFR*3*89Histone 1, H2ai isoform 3-like protein\*S9 × 8G9_CAMFR*2*88DesmoplakinA2V743_CAMDR*2*85Beta actinA0A0A0PAR2_CAMDR*2*85Heat shock protein 90S9XA40_CAMFR*1*85Heat shock cognate proteinT0NNK2_CAMFR*1*81L-lactate dehydrogenaseS9XNF8_CAMFR*2*74Xaa-Pro dipeptidaseT0MHN9_CAMFR*1*71Pyruvate kinaseS9WVY1_CAMFR*1*60Actinin, alpha 1 isoform 6-like protein\*A0A0E3Z5I3_CAMDR*1*59Superoxide dismutaseS9XHZ4_CAMFR*1*57Phosphotriesterase-related proteinS9W9Y4_CAMFR*1*57FerritinS9XR87_CAMFR*1*56Ig lambda chain C regions isoform 19-like proteinS9 × 3E8_CAMFR*1*50Ig kappa chain V-II region RPMI 6410-like proteinS9WAX5_CAMFR*2*49Unconventional myosin-Va isoform 2S9WF34_CAMFR*1*44Tubulin alpha chain\*S9W806_CAMFR*2*43Filamin-A isoform 1\*S9 × 6X3_CAMFR*2*42Scaffold attachment factor B-like proteinT0MH94_CAMFR*1*40Rabenosyn-5-like protein\*S9Y0S0_CAMFR*1*39DNA-directed RNA polymerase subunit betaS9WJW3_CAMFR*1*38N6-adenosine-methyltransferase subunitS9XM68_CAMFR*1*38Xaa-Pro dipeptidase isoform 3\*S9YV02_CAMFR*1*38Non-specific protein-tyrosine kinaseS9WGH8_CAMFR*1*32LysozymeS9WRI7_CAMFR*1*32Nuclear receptor coactivator 5 isoform 3-like proteinS9W421_CAMFR*1*32Hemoglobin, epsilon 1\*S9WI71_CAMFR*1*32Metabotropic glutamate receptor 3\*S9WB50_CAMFR*1*31TSC22 domain family protein 3-like proteinS9WMX2_CAMFR*1*31DystoninS9WKI8_CAMFR*1*31HEAT repeat-containing protein 7B1S9WIA5_CAMFR*1*31Glutathione synthetase\*S9XC05_CAMFR*1*31Telomere-associated protein RIF1 isoform 1A0A0U2KTX5_CAMDR*1*30VHH5\*T0MGG7_CAMFR*1*30Nucleoredoxin\*S9XET3_CAMFR*1*30Rac GTPase-activating protein 1S9XDK9_CAMFR*1*30Complement C3-like protein\*S9XMI2_CAMFR*1*29Pseudopodium-enriched atypical kinase 1\*S9Y3S9_CAMFR*1*29Core histone macro-H2A.1 isoform 2S9XXW2_CAMFR*1*29Fibrinogen beta chain\*S9YGX6_CAMFR*1*29PAS domain-containing serine/threonine-protein kinase\*T0NMU1_CAMFR*1*28SH2 domain-containing protein 7\*T0MIT6_CAMFR*1*28Serine-tRNA ligase, mitochondrial\*S9W449_CAMFR*1*28Fc receptor-like protein 5[^2]

4. Discussion {#sec0060}
=============

For the first time deiminated proteins are described in a camelid, using the llama (*Lama glama*) as a model species. Post-translational deimination was identified in key immune, nuclear and metabolic proteins. A llama PAD homologue was identified at an expected 70--75 kDa size similar as for human PADs by Western blotting via cross reaction with anti-human PAD2, PAD3 and PAD4 antibodies. PAD2 is known to be the phylogenetically most conserved PAD form ([@bib1125]; [@bib0685]) and has also been seen in shark ([@bib0200]). Deiminated histone H3, a marker of neutrophil extracellular trap formation (NETosis), was also detected in llama serum by Western blotting and is described for the first time in a camelid species but was recently described in shark ([@bib0200]). NETosis is driven by PADs ([@bib0650]), is conserved throughout phylogeny and is important in innate immune defences against a range of pathogens including bacteria, viruses and helminths ([@bib0145]; [@bib0140]; [@bib0955]). NETosis has also been associated with clearance of apoptotic cells and during tissue remodelling in teleosts ([@bib0685], [@bib0695]). Furthermore, NETosis is linked to a range of autoimmune diseases, due to NET activation via neo-epitopes ([@bib0815]), which can also lead to organ damage ([@bib0635]). NETosis is also associated with cancer ([@bib0380]) and neurodegenerative diseases ([@bib0845]).

Further deiminated proteins identified in llama serum and serum-derived EVs by F95 enrichment and LC---MS/MS analysis included key proteins of camelid innate and adaptive immunity, nuclear proteins, as well as proteins involved in metabolic function. Using STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) analysis (<https://string-db.org/>) for protein-protein interaction, the PPI enrichment value for deiminated proteins in whole llama serum was found to be *p* \<  1.0e-16 for 43 deiminated proteins out of 103 identified in serum, which indicates that these proteins have more interactions among themselves than what would be expected for a random set of proteins of similar size, drawn from the genome (STRING analysis, see [Fig. 3](#fig0015){ref-type="fig"} A). For deiminated proteins in 29 out of the 68 deiminated EV cargo proteins, the PPI enrichment value was found to be *p* = 0.0193 (STRING analysis, see [Fig. 4](#fig0020){ref-type="fig"} A). Such enrichment indicates that the proteins are at least partially biologically connected, as a group. As the camelid proteins are not present in the STRING database, corresponding protein homologues for human were chosen to create the protein-protein interaction networks shown in [Fig. 3](#fig0015){ref-type="fig"}, [Fig. 4](#fig0020){ref-type="fig"}. Out of the 103 camelid proteins identified as deiminated in serum, protein IDs for 43 were present for *Homo sapiens* to perform the assessment of protein-protein interactions and identification of main biological GO pathways (response to stress, response to wounding, oxygen transport, small molecule metabolic process, vesicle mediated transport and regulated exocytosis; [Fig. 3](#fig0015){ref-type="fig"}B). For llama EVs, out of 68 proteins identified as deiminated, 29 corresponding protein homologues were found in the STRING database for *Homo sapiens* and were analysed highlighting main biological GO pathways (response to stress, cytoskeleton organisation and vesicle-mediated transport; [Fig. 4](#fig0020){ref-type="fig"}B).Fig. 3Protein-protein interaction networks of deiminated protein hits identified in whole llama (*Lama glama*) serum. Reconstruction of protein-protein interactions based on known and predicted interactions using STRING analysis. Due to annotations for camelids not being present in STRING, proteins are based on corresponding human protein identifiers. **A.** Coloured nodes represent query proteins and first shell of interactors; white nodes are second shell of interactors. **B.** Biological GO processes are highlighted for the same protein network as follows: red = response to stress; blue = response to wounding; green = vesicle mediated transport; yellow = oxygen transport; purple = regulated exocytosis; dark green = small molecule metabolic process. Coloured lines indicate whether protein interactions are identified via known interactions (curated databases, experimentally determined), predicted interactions (gene neighbourhood, gene fusion, gene co-occurrence) or via text mining, co-expression or protein homology (see colour key for connective lines in A).Fig. 3Fig. 4Protein-protein interaction networks of deiminated protein hits identified in EVs of llama (*Lama glama*) serum. Reconstruction of protein-protein interactions based on known and predicted interactions using STRING analysis. Due to annotations for camelids not being present in STRING, proteins are based on corresponding human protein identifiers. **A.** Coloured nodes represent query proteins and first shell of interactors. **B.** Biological GO processes are highlighted as follows: red = response to stress; blue = cytoskeleton organisation; green = vesicle mediated transport. Coloured lines indicate whether protein interactions are identified via known interactions (curated databases, experimentally determined), predicted interactions (gene neighbourhood, gene fusion, gene co-occurrence) or via text mining, co-expression or protein homology (see colour key for connective lines in A).Fig. 4

Deimination protein candidates identified here in llama serum and EVs, which are involved in immune, nuclear and metabolic functions, are further discussed below, including where appropriate in a comparative context with relevant human diseases. Proteins that have previously been identified as deiminated in other species are listed first.

***Nanobodies*** are based on immunoglobulin single variable domains, derived from the variable domains of heavy chain-only antibodies, which occur naturally in camelids ([@bib0240]). In the llama the heavy chain-only antibodies are comprised of at least two subclasses ([@bib0460]). These types of homodimeric, light chain-less antibodies have evolved through convergent evolution ([@bib0150]), in at least two groups (camelids and cartilaginous fish), and their variable binding domains (V~H~H~S~) are of great value for therapeutic and diagnostic applications ([@bib0755]; [@bib0195]; [@bib1030]; [@bib0560]; [@bib0460]). Nanobodies can act against challenging targets such as small molecules and toxins ([@bib1170]; [@bib0110]), viruses ([@bib1150]; [@bib0445]; [@bib1095]; [@bib0185]), enzymes ([@bib0755]), ion channels ([@bib1150]; [@bib0210]) and G protein-coupled receptors GPCRs ([@bib0205]). Llama nanobodies have been shown to tether to early endosomes and to mitochondria ([@bib1070]), be used for diagnostics ([@bib0980]), be used for design of cancer immunotherapeutics ([@bib0485]; [@bib0060]; [@bib0915]) and have been approved for passive immunotherapy ([@bib0975]). Our current finding, that llama nanobodies can be post-translationally deiminated may shed some light on their observed structural variation which still remains to be fully explained as sequence alignment does not fully elucidate their diversity ([@bib0735]). As a structurally analogous immunoglobulin in shark, new antigen receptor (NAR) ([@bib0400]; [@bib0075]; [@bib0330]; [@bib0230]) was recently also found to be deiminated ([@bib0200]), our current finding may provide novel insights into function of these immune proteins and be useful for refinement in therapeutic nanobody development. Llama single-chain antibodies were here found to be deimination candidates both in llama whole serum and in serum derived EVs, highlighting also their EV-mediated export.

***Ig proteins*** were identified here as being deiminated in llama serum and in serum-derived EVs, scoring with Ig components from other camelids. Immunoglobulins (Ig) are key molecules in adaptive immunity but post-translational deimination of Ig's has hitherto received little attention. Deimination of the IgG Fc region in patients with bronchiectasis and RA has been identified ([@bib0490]). Furthermore, deimination of Ig's in teleost fish was recently described ([@bib0695]), as well as in shark ([@bib0200]). Given the increased focus on understanding of Ig diversity throughout phylogeny ([@bib0995]; [@bib1225]; [@bib0220]; [@bib1235], [@bib1240]; [@bib1025]) and the unique features of camelid immunoglobulins ([@bib0850]), our current finding of deimination of llama Ig's highlights a novel concept that may further understanding of Ig diversity throughout evolution. Of additional interest is the finding that some deiminated Ig proteins were also found to be exported in EVs.

***Complement components*** identified to be deiminated in llama serum included C3, C4 and C1q, while only C3 was identified to be deiminated in serum derived EVs. Complement component C3 plays a central role in all pathways of complement activation and can also be directly activated by self- and non-self surfaces via the alternative pathway without a recognition molecule ([@bib0260]; [@bib0255]). In camelids, the alternative and classical pathway haemolytic activity of serum has been assessed in the dromedary camel with respect to age and gender ([@bib0805]; and [@bib0810]). Hitherto little is known about roles for post-translational deimination of complement components throughout phylogeny. In teleost fish, C3 has been identified in serum in deiminated form ([@bib0695]) and also found to be deiminated in mucosal and serum EVs of teleost fish ([@bib0700], [@bib0705]), while post-translationally deiminated C3 was identified in shark total serum but not EVs ([@bib0200]). Other complement components, including C4 and C1q, which belong to the classical pathway of complement activation were here identified as deiminated in llama whole serum and some of those have also recently been reported to be deiminated in teleost fish ([@bib0695]). The C1q subcomponent can bind to the Fc region of immunoglobulins that are bound to antigen and activate the classical part of the complement pathway ([@bib0890]; [@bib0895]). Interestingly, an essential role for arginine in C1q has previously been suggested for C1q-IgG interaction ([@bib0555]). C1q also serves as a potent pattern recognition molecule which recognises self, non-self and altered self-signals ([@bib0770]; [@bib0895]) and may therefore also bind to deiminated neo-epitopes ([@bib0695]). The complement system has multifaceted roles. It forms part of the first line of immune defence against invading pathogens, acting in clearance of necrotic or apoptotic cells ([@bib0260]; [@bib1035]; [@bib0315]; [@bib0160]). Complement also has roles in regeneration ([@bib0235]; [@bib0450]) and tissue remodelling ([@bib0590], [@bib0595]; [@bib0600], [@bib0605], [@bib0625]). Furthermore, C1 is also implicated in multiple non-complement functions including binding of apoptotic cells, cleavage of nuclear antigens and cleavage of MHC class I ([@bib0675]). Post-translational deimination of complement components may possibly influence their function including cleavage ability, binding, deposition and generation of the convertase.

***Apolipoprotein A--I*** is primarily involved in lipid metabolism where conformational plasticity and flexibility are regarded as key structural features ([@bib0030]). Apo A--I is associated with regulation of mitochondrial function and bioenergetics ([@bib1175]). Furthermore, Apo A--I has been shown to have a regulatory role in the complement system by affecting membrane attach complex (MAC) assembly and thus the final lytic pathway ([@bib0430]; [@bib0525]; [@bib0350]). Given the diverse roles of Apo A--I, the current finding of deiminated forms in serum may be of quite some relevance and has previously been identified in teleost fish ([@bib0695]). Apo A--I was here found to be deiminated in whole llama serum only.

***Serum albumin*** is a major acidic plasma protein in vertebrates and serves as a transport molecule for fatty acids, bilirubin, steroids, amino acids and copper, as well as having roles in maintaining the colloid osmotic pressure of blood ([@bib0835]). In camelids, total albumin levels have been assessed, for example in relation to reproductive efficiency ([@bib0295]) and as biomarkers of oxidative stress ([@bib0290]). While albumin has been identified as a glycoprotein in some species ([@bib0725]) investigation of post-translational deimination has been limited, but was recently identified in teleost fish ([@bib0695]). Serum albumin was identified as deiminated in both whole llama serum and EVs.

***Hemopexin*** is a scavenger protein of haemoglobin and a predominant heme binding protein, which contributes to heme homeostasis ([@bib1000]; [@bib0500]). Hemopexin also associates with high density lipoproteins (HDL), influencing their inflammatory properties ([@bib0720]). Hemopexin is a plasma glycoprotein that has been previously identified as a deimination candidate in teleost fish ([@bib0695]) and shark ([@bib0200]). Here, hemopexin was found deiminated in whole llama serum only.

***Inter-alpha-trypsin inhibitor*** (heavy chain H1) belongs to the serpin family of proteins, which have protease-inhibitory functions and are involved in diverse physiological and pathological processes including fertilisation, ovulation, coagulation, inflammation, as well as tumorigenesis, metastasis and dementia ([@bib1255]; [@bib1155]). Inter-alpha-trypsin inhibitor is synthesised in the liver, circulates in the blood and has two chains, a light and heavy chain, whereof the heavy-chain (ITIH) includes a von Willebrand domain and can interact with the extracellular matrix ([@bib0135]). ITIH is downregulated in tumours via methylation and ITIH2 is strongly reduced in invasive cancers ([@bib0435]). While ITIH was recently identified as a deimination candidate in teleost fish ([@bib0695]) further studies on the regulation of ITIH2 via post-translational deimination have not been carried out. ITIH was here identified as deiminated in whole llama serum only.

***Fibrinogen*** is a glycoprotein, synthesised in liver ([@bib1055]) and forms part of the acute phase response as part of the coagulation cascade ([@bib1065]). In camelids, fibrinogen is a biomarker for stress and infection ([@bib0405]; [@bib0285]; [@bib0290]). Impaired mechanism of fibrinogen formation and fibrin polymerization are implicated with various pathologies including coagulopathies and ischemic stroke ([@bib1160]), while acquired fibrinogen disorders can be associated with cancer, liver disease or post-translational modifications ([@bib0105]). Fibrinogen is indeed a known deimination candidate and this post-translational modification contributes to its antigenicity in autoimmune diseases ([@bib0470]; [@bib0750]; [@bib0130]). Fibrinogen was here identified as deiminated both in whole llama serum and EVs.

***Tubulin beta-chain*** participates in cytoskeletal rearrangement and its deimination has previously been linked to EV release ([@bib0535]). Deimination of tubulin may therefore be crucial for facilitating EV-mediated processes in homeostasis, immune responses and in relation to pathologies. Here, tubulin was identified as deiminated in both whole llama serum and EVs.

***Histone H2B*** was identified as being deiminated in both llama serum and EVs and in addition, Histone 1 (H2ai isoform 3-like protein) and core histone macro-H2A.1 isoform 2 were identified as deiminated in EVs only. Histones undergo various posttranslational modifications that affect gene regulation and can also act in concert ([@bib0630]; [@bib0120]). In addition to acetylation, phosphorylation and ubiquitination, histones are known to undergo deimination, including H2B ([@bib1005]) and H2A ([@bib0425]), as identified in this study in llama. Other histones that are known to undergo deimination include H3 and H4 ([@bib0165]; [@bib0575]).

***Heat shock protein 90*** (Hsp90) was here found to be deiminated both in llama whole serum and EVs. HSP90 has been described in camelid ([@bib0920]). Hsp90 is a phylogenetically highly conserved chaperone protein involved in protein folding, stabilisation of proteins against heat stress, and aids in protein degradation ([@bib0155]; [@bib0840]). Hsp90 also stabilizes a number of proteins required for tumour growth and is therefore important in anti-cancer drug investigations ([@bib0375]). Hsp90 is responsible for most of the ATPase activity of the proteasome ([@bib0505]) and has an ATP binding region, which also is the main binding site of drugs ([@bib0180]). In camelids, Hsp90 has been related to adaptive tolerance of camel somatic cells to acute and chronic heat shock (up to 20 h at 45 degrees Celsius), which is lethal to many mammalian cells ([@bib0930]). Hsp90 has previously been described to be post-translationally deiminated in rheumatoid arthritis, allowing deimination-induced shifts in protein structure to generate cryptic epitopes capable of bypassing B cell tolerance ([@bib1075]). It is of some interest to find that Hsp90 is also found deiminated in llama serum, further highlighting protein moonlighting functions of Hsp90 in physiological and pathophysiological context via post-translational deimination. In addition, finding post-translational deimination of the same protein throughout phylogeny also supports translational value between species to further understanding of this post-translational modification in human pathologies.

The following deimination protein candidates identified in the current study in llama serum and serum-EVs have to our knowledge not been previously reported as deiminated:

***Alpha 2-macroglobulin*** is closely related to other thioester containing proteins, such as complement proteins C3, C4 and C5 ([@bib1010]; [@bib0215]). Alpha-2-M is phylogenetically conserved from arthropods to mammals and found at high levels in mammalian plasma. Alpha-2-M forms part of the innate immune system and clears active proteases from tissue fluids ([@bib0035]). Here, Alpha-2-M was found deiminated in whole llama serum only and has not reported as deiminated before, to our knowledge.

***Adiponectin*** is the most abundant secreted adipokine with pleiotrophic roles in physiological and pathophysiological processes ([@bib0320]). It has received considerable interest in the field of metabolic and obesity research ([@bib0345]; [@bib1015]), as well as in diabetes ([@bib1205]), due to its key function in regulating glucose ([@bib1200]). Adiponectin is furthermore linked to longevity ([@bib0170], [@bib0175]), regenerative functions ([@bib0325]) and has roles in myopathies, such as Duchenne muscular dystrophy and collagen VI-related myopathies ([@bib0360]). Adiponectin is also implicated in a range of cancers, often in relation to obesity ([@bib0820]). Furthermore, adiponectin plays roles in reproduction, embryo pre-implantation and embryonic development ([@bib0070]). Due to the range of functions in relation to key pathophysiologies there is great interest in drug development for modulating adiponectin signalling ([@bib0320]). Given the unique metabolic adaptive features of camelids, the identification of post-translational deimination of this key metabolic protein may be of some interest. Recent studies in rheumatoid arthritis made a correlation between inflammation, autoantibodies and adiponectin levels ([@bib0475]; [@bib0670]), while adiponectin itself has not been previously identified to be deiminated to our knowledge. Post-translational deimination may be a hitherto unrecognized mechanism for adiponectin, also in humans, to adapt moonlighting functions via changes in protein folding and therefore interaction with other proteins. Adiponectin is a small 244 aa protein (NP_001171271.1) in humans and contains 2 unfolded regions and 7 arginine sites, while camel adiponectin has 8 arginine sites. These could be subjected to PAD-mediated deimination and therefore modulate adiponectin folding and function, depending on which arginine is deiminated. Here, deiminated adiponectin was identified in whole llama serum only.

***Dystonin*** is a plakin-family adhesion junction plaque protein and was here identified as deiminated in both llama serum and EVs. Dystonin, along with XVII collagen, form hemidesmosomes and both proteins are autoantigens believed to be responsible for the Type II hypersensitivy pathologic in the pruritic skin disease bullous pemphigoid ([@bib0050]; [@bib0085]). Dystonin has also been linked to Sjögren's syndrome and linked to a hypermethylation status ([@bib0385]), but post-translational deimination of dystonin has not been previously described to our knowledge, although deimination is associated with a range of autoimmune diseases, including Sjögren's syndrome ([@bib0565]; [@bib0965]).

***Xaa-Pro dipeptidase,*** also known as prolidase, is an enzyme that in humans is encoded by the PEPD gene. Post-translational modifications of prolidase regulate its enzymatic abilities. Deficiency in prolidase leads to a rare, severe autosomal recessive disorder (prolidase deficiency) that causes many chronic, debilitating health conditions in humans ([@bib1120]). These phenotypic symptoms vary and may include skin ulcerations, mental retardation, splenomegaly, recurrent infections, photosensitivity, hyperkeratosis, and unusual facial appearance. Furthermore, prolidase activity was found to be abnormal compared to healthy levels in various medical conditions including: bipolar disorder, breast cancer, endometrial cancer, keloid scar formation, erectile dysfunction, liver disease, lung cancer, hypertension, melanoma, and chronic pancreatitis ([@bib0545]). In some cancers with increased levels of prolidase activity, such as melanoma, the differential expression of prolidase and its substrate specificity for dipeptides with proline at the carboxyl end suggests the potential of prolidase in becoming a viable, selective endogenous enzyme target for proline prodrugs ([@bib0740]). Serum prolidase enzyme activity is also currently being explored as a biomarker for diseases including chronic hepatitis B and liver fibrosis ([@bib0275]; [@bib0970]; [@bib1020]). Phosphorylation of prolidase has been shown to increase its activity while dephosphorylation leads to a decrease in enzyme activity. Post-translational deimination of prolidase has not been described before to our knowledge and may add to understanding of how this enzyme is regulated. Prolidase was here identified as deiminated in both llama serum and EVs.

***Dipeptidylpeptidase 4*** (DPP4, also known as CD26) was here identified to be deiminated in both llama whole serum and EVs. DPP4 controls glucose homeostasis and has complex roles in inflammation and homeostasis, including in liver cytokine expression, while its activity in plasma has been shown to correlate with body weight and fat mass ([@bib1105]). Interestingly, in camel milk, DDP4 inhibitory peptides have been identified and suggested to play roles in the regulation of glycaemia in humans ([@bib0795]). Furthermore, roles for DDP4 in cancer have been found to relate to its post-translational processing of chemokines, thereby limiting lymphocyte migration to sites of inflammation and tumours ([@bib0080]). As the success of antitumour immune responses depends on the infiltration of solid tumours by effector T cells, a process which is guided by chemokines, DPP4 inhibitors have been suggested as a strategy to enhance tumour immunotherapy ([@bib0080]). Furthermore, serum DDP4 activity levels in primary HIV infection were found to be significantly decreased and to correlate with inflammation and HIV-induced intestinal damage ([@bib0855]). Middle East respiratory syndrome coronavirus (MERS-CoV) has been found to utilize dipeptidyl peptidase 4 (DPP4) as an entry receptor, via glycosylated sites ([@bib0825]). Therefore the identification of DPP4 as a deimination candidate may be of some relevance as such post-translational modification can affect DPP4 structure and function, allowing for moonlighting functions which may vary in pathological compared to pathophysiological milieus.

***E3 ubiquitin-protein ligase Roquin***, belongs to the Roquins which are a family of highly conserved RNA-binding proteins involved in ubiquination, are crucial for T-cell-dependent B-cell responses ([@bib0040]) and play important roles in modulating T-cell activity ([@bib0010]). Roquins repress constitutive decay elements containing mRNAs and play a critical role in RNA homeostasis and immunological self-tolerance ([@bib1230]; [@bib0310]; [@bib0730]). Roquin plays multifaceted roles both in the generation of a homeostatic immune response, as well as during chronic inflammation and autoimmunity ([@bib0940]; [@bib0640]). While roquin causes post-translational ubiquination of target proteins, post-translational deimination of roquin itself may modulate is function and is described here for the first time. Roquin was here identified as deiminated in whole llama serum only.

***Serine-tRNA ligase, mitochondrial*** was here identified as a deimination candidate protein in llama EVs only. It has been linked to HUPRA syndrome which is a rare mitochondrial disease characterized by hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis ([@bib0910]). It has furthermore been linked to progressive spastic paresis ([@bib0660]). Post-translational deimination of this mitochondrial protein has not been described before to our knowledge.

***Nucleoredoxin*** (Nrx) was here identified to be deiminated in EVs only. It is an oxidoreductase of the thioredoxin family of proteins with numerous functions in the redox regulation of metabolic pathways, cellular morphology, and signal transduction ([@bib1085]). Nrx has been shown to inhibit Wnt-beta-catenin signalling ([@bib0355]) and is linked to Ca^2+^-mediated mitochondrial reactive oxygen species metabolism ([@bib0900]). Nrx has furthermore been identified as an epigenetic cancer marker related to the oxidative status of human blood ([@bib0960]), but hitherto not been described as deiminated.

***Dyslexia-associated protein*** was here identified to be deiminated in total serum of llama. It is associated with developmental dyslexia ([@bib0645]) and has been shown to have roles in cell-cell interactions and signalling and neuronal migration ([@bib1110]), as well as in axon guidance ([@bib0860]). Dyslexia-associated protein has previously been found to follow the classical clathrin-mediated endocytosis pathway and its surface expression seems regulated by endocytosis, indicating that the internalization and recycling of the protein may be involved in fine-tuning its role in neuronal migration ([@bib0645]). It has been descried to be highly glycosylated in different mammalian cell lines ([@bib1110]), while deimination has not been described before.

***Metabotropic glutamate receptor 3*** was identified here as deiminated in llama EVs only. It has, like other components of the glutamatergic system, a widespread distribution outside the central nervous system (CNS) and has been linked to regulation of the brain-gut axis ([@bib0530]). It has also been linked to pain ([@bib0005]) and psychotic disorders ([@bib0715]). The group III mGlu receptors have been described in human stomach and colon, revealing a huge potential for these receptors in the treatment of peripheral disorders, including gastrointestinal dysfunction ([@bib0530]). As post-translational deimination has not been described before in this receptor, but may well affect is tertiary structure, our current finding may be of some relevance in relation to strategies for developing antagonistic probes ([@bib1165]). Such pharmacological tools originally designed for mGlu receptors in the CNS may also be directed towards new disease targets in the periphery. Ulcerative colitis and Crohn's disease are potential targets, as irritable bowel diseases can be co-morbid with anxiety and depression ([@bib0530]).

***Glutathione synthetase*** (GSS) was here identified to be deiminated in both llama whole serum and EVs. GSS is the second enzyme in the glutathione (GSH) biosynthesis pathway involved in homeostasis and cellular maintenance and also acts as a potent antioxidant ([@bib0785]). In camelids, glutathione peroxidase, which also belongs to the GSH biosynthesis pathway and is a potent anti-oxidant, has been identified as a seminal plasma fertility biomarker ([@bib1135]). Furthermore, camel milk has been shown to boost glutathione and total anti-oxidant capacity in sera and exudates in animal studies ([@bib0025]). In a diabetic mouse model, the activities of GSH, alongside glucose insulin and ROS levels, were restored after camel whey protein treatment ([@bib0935]). In humans, GSS deficiency is an autosomal recessive disorder with varyingly severe clinical manifestations that include metabolic acidosis, hemolytic anemia, hyperbilirubinemia, neurological disorders and sepsis ([@bib0415]). Deimination of GSS identified here has not been assessed before and may possibly affect the GSH biosynthesis pathway and such post-translational regulation remains to be further investigated.

***Rootletin***, also known as ciliary rootlet coiled-coil protein (CROCC), is a protein that is required for centrosome cohesion and is therefore important in mitosis ([@bib0055]; [@bib0390]). It was identified here as deiminated in whole llama serum only. Rootletin has been shown to be phosphorylated and to have the ability to form centriole-associated fibers, suggesting a dynamic model for centrosome cohesion based on entangling filaments ([@bib0055]). Deletion of rootletin in mouse models causes photoreceptor degeneration and impaired mucociliary clearance, supporting its key function in rootlet structures ([@bib1210]). Post-translational deimination of rootletin, as identified here, may possibly facilitate its dynamic functions.

***Centromere protein J*** is is a highly conserved and ubiquitiously expressed centrosomal protein, involved in microtubule disassembly and plays a structural role in the maintenance of centrosome integrity, genome stability and normal spindle morphology during cell division ([@bib1040]; McIntyre, 2012). It was here identified as deiminated in whole llama serum only. Knockout mouse models targeting the gene encoding this protein have phenotypes of impaired glucose tolerance, hypoalbuminemia and increased micronuclei, indicative of genomic instability ([@bib0370]). In humans, it is associated with primary autosomal recessive microcephaly ([@bib0410]) and the microcephalic primordial dwarfism disorder Seckel syndrome ([@bib0015]; [@bib0710]). Deimination has not bee described before in this protein to our knowledge.

***Telomere-associated protein RIF1 isoform* 1** is involved in the repair of double-strand DNA breaks in response to DNA damage ([@bib0985]; [@bib0305]; [@bib0265]) and protects teleomeres ([@bib0335]). It was identified here as deiminated in EVs only. RIF1 has been associated with cancer via activation of human telomerase reverse transcriptase expression ([@bib0665]). It is also required for immunoglobulin class-switch recombination during the germinal centre reaction for humoral antibody immunity ([@bib0250]). RIF1 is involved in telomere homeostasis and was recently found to be post-translationally S-acylated, identifying a novel posttranslational modification regulating DNA repair ([@bib0340]). Post-translational deimination has hitherto not been described.

***Rabenosyn-5-like protein*** was here identified as a deimination protein candidate in both llama whole serum and EVs. It acts in early endocytic membrane fusion and membrane trafficking of recycling endosomes ([@bib0760]; [@bib0865]). It plays a role in the lysosomal trafficking of CTSD/cathepsin D from the Golgi to lysosomes and also promotes the recycling of transferrin directly from early endosomes to the plasma membrane ([@bib0765]). Rabenosyn-5-like protein also binds phospholipid vesicles and plays roles in regulating protein sorting and recycling to the plasma membrane ([@bib0780]; [@bib0225]; [@bib0760]). Rabenosyn-5 was recently identified as an upregulated urinary biomarker associated with malignant upper gastrointestinal cancer ([@bib0480]) and found to be increased in diabetic kidney disease ([@bib0270]). Rabenosyn-5 has been shown to be phosphorylated, regulating its recruitment to membranes ([@bib0680]). Post-translational deimination has hitherto not been described..

***Spermatogenesis-associated protein 2 (SPATA2)*** was here identified as deiminated in whole llama serum only. It is expressed in testis and to a lesser extent in spleen, thymus, and prostate ([@bib0395]). SPATA2 has been identified as a bridging factor that regulates TNF-alphA--Induced necroptosis and is instrumental for TNF-induced cell death ([@bib0300]; [@bib0585]; [@bib0945]; [@bib1130]; [@bib0950]). SPATA2 ensures normal secretory function of Sertoli cells ([@bib1245]) and has recently been identified as a novel predictor in ovarian cancer outcome ([@bib1180]). While SPATA2 has been linked to ubiquination ([@bib0945]), post-translational deimination has not been invesigated.

***Vitamin*** D-***binding protein (VDBP)*** belongs to the albumin gene family, together with human serum albumin and alpha-fetoprotein. It is a multifaceted protein mainly produced in the liver, where its regulation is influenced by estrogen, glucocorticoids and inflammatory cytokines ([@bib0125]). It is secreted into the blood circulation and is able to bind the various forms of vitamin D including ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3), the 25-hydroxylated forms (calcifediol), and the active hormonal product 1,25-dihydroxyvitamin D (calcitriol) ([@bib1115]; [@bib0800]). It transports vitamin D metabolites between skin, liver and kidney, and then on to various target tissues ([@bib0800]). VDBP is a macrophage activating factor (MAF) and has been tested as an anti-cancer agent via activation of macrophages against cancer cells ([@bib1195]). Some association has also been made between polymorphisms of VDBP and the risk of coronary artery disease ([@bib1045]). Post-translational modifications (which still remain to be identified) of VDBP have been associated with multiple sclerosis (MS) ([@bib0830]), while protein deimination is well known to be associated with MS ([@bib0745]). VDBP has previously been identified to be glycosylated ([@bib0540]) but was here identified as a deimination candidate in whole llama serum only. Post-translational deimination may contribute to various functions of VDBP in physiological as well as pathophysiological processes.

***Pseudopodium-enriched atypical kinase 1*** (PEAK1) was here identified as deiminated in EVs only. It is a tyrosine kinase and scaffold protein that transmits integrin-mediated extracellular matrix (ECM) signals to facilitate cell movement and growth. While aberrant expression of PEAK1 has been linked to cancer progression, its normal physiological role in vertebrate biology is still relatively unknown. Deletion of the PEAK1 gene in zebrafish, mice and human endothelial cells (ECs) induced severe defects in new blood vessel formation due to deficiencies in EC proliferation, survival and migration. PEAK1 seems therefore to play roles in modulation of cell adhesion and growth factor cues from the extracellular environment necessary for new vessel formation during vertebrate development and cancer ([@bib1145]). PEAK1 has not been described as deiminated before.

***Desmoplakin*** was here identified to be deiminated in llama EVs only. Desmoplakin is a unique and critical component of desmosomal cell-cell junctions and involved in integrity of the cytoskeletal intermediate filament network ([@bib0095]). It has been shown to be required for epidermal integrity and morphogenesis in the *Xenopus laevis* embryo ([@bib0065]) and novel roles in coordination of cell migration were recently established ([@bib0095]). Mutations in desmoplakin have been linked to multiple allergies, severe dermatitis and metabolic wasting (SAM) syndrome ([@bib0655]). It is also linked to Carvajal syndrome, involving altered skin and hair abnormalities, and heart diseases ([@bib1220]), including cardiomyopathies ([@bib0885]; [@bib0170], [@bib0175]). Desmosomal proteins have been shown to have both tumour-promoting and tumour-suppressive functions, depending of cancer types and can regulate cell proliferation, differentiation, migration, apoptosis, and impact treatment sensitivity in different types of cancers ([@bib1250]). As the roles of desmosomal proteins in cancer and metastasis are not fully understood, the identification of deiminated desmoplakin in llama EVs here, and not described before, may be of some interest and add to understanding of diverse functional ability via such post-translational modification.

***TSC22 domain family protein 3***, also called glucocorticoid-induced leucine zipper protein (GILZ), was here identified as a deimination candidate in llama EVs only. It is a glucocorticoid-responsive molecule involved in immune regulation and glucocorticoid actions. Its interactions with signal transduction pathways, many of which are operative in RA and other inflammatory diseases, suggest that it is a key endogenous regulator of the immune response including a key glucocorticoid-induced regulator of inflammation in rheumatoid arthritis (RA) ([@bib0090]). GILTZ is a small, 135-amino acid protein with anti-inflammatory properties and has been shown to inhibit NF-κB and MAPK pathways ([@bib0100]; [@bib0905]). It has also been shown to be induced in response to hypoxia by a HIF1α-dependent mechanism and in response to cholesterol starvation, leading to downstream shedding of procoagulant EVs in ovarian cancer ([@bib0550]). Post-translational deimination of GILZ has not been described before but may indeed affect its multifaceted functions, including in inflammation and cancer.

In the current study we report deiminated proteins in llama serum and serum-derived EVs. Due to the fact that the llama genome is not yet fully annotated, the hits identified here may underestimate the amount of deiminated proteins present in llama serum and EVs. Therefore a wider protein-hit analysis was carried out including other members of the camelid family, using known sequences from *Camelus ferus*, *Camelus dromedaries*, *Lama guanicoe* and *Vicugna pacos*. Deimination of key immune factors of innate and adaptive immunity and key metabolic proteins is identified here for the first time in a camelid species, highlighting putative protein moonlighting functions via post-translational deimination. It must be noted that in relation to previously observed increases of deiminated proteins with age ([@bib0245]), the llama used in this study would be considered relatively old at 21 years of age, as typical llama lifespans are 15--25 years, with some individuals surviving 30 years or more.

Our findings presented here furthermore complement expanding research in the comparative EV research field. Previous studies on the camel urinary proteome revealed enriched proteins from EVs and relevance to stress and immune responses as well as antimicrobial activities ([@bib0020]). Research on EVs is a relatively new field in comparative immunology and to our knowledge; this is the first description of EVs in serum of a camelid species. Previous studies on EVs in camelids focussed on EVs in camel milk, which were shown to have anti-cancerous properties ([@bib0045]). As PADs have been identified to play major roles in the regulation of EV release ([@bib0535]; [@bib0570] and 2018), including in host-pathogen interactions ([@bib0365]), such EV-mediated communication may be of great relevance also for addressing diverse zoonotic diseases identified in camels ([@bib0280]; [@bib1260]).

In continuation of the current pilot study, the assessment of changes in deiminated proteins in camelid serum, and their lateral transfer via EVs, will be of great interest to assess animal health in response to infection and environmental stress. Our findings will further current understanding of the roles for EVs, PADs and posttranslational deimination throughout phylogeny and in relation to adaption to a range of, including extreme, environments. Furthermore, novel identification of post-translational deimination in key proteins of metabolism and immunity may reveal hitherto unrecognized moonlighting function of these proteins throughout phylogeny, in relation to physiological and pathological processes, as well as being translational to and informing inflammatory and metabolic diseases. PAD-mediated contribution to protein moonlighting and in EV-mediated communication in response to physiological and pathophysiological changes remains therefore a field of further studies.

5. Conclusion {#sec0065}
=============

This is the first report of deiminated proteins in serum and serum-EVs of a camelid species, using the llama as a model animal. Our findings highlight a hitherto unrecognized post-translational modification in key immune and metabolic proteins in camelids, which may be translatable to and inform a range of human metabolic and inflammatory pathologies.
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[^1]: Ions score is -10\*Log(P), where P is the probability that the observed match is a random event. Individual ions scores \> 20 indicated identity or extensive homology (*p* \< 0.05). Protein scores were derived from ions scores as a non-probabilistic basis for ranking protein hits. Cut-off was set at Ions score 20.

[^2]: Ions score is -10\*Log(P), where P is the probability that the observed match is a random event. Individual ions scores \> 22 indicated identity or extensive homology (*p *\< 0.05). Protein scores were derived from ions scores as a non-probabilistic basis for ranking protein hits. Cut-off was set at Ions score 20.
